Stocks · Korea
101140
KOSPI
Inbiogen
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+14.67%
1M-7.80%
3M-8.47%
6M-42.21%
1Y-58.70%
YTD-55.40%
52W high14,300원
52W low4,255원
From 52W high-64.48%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 114억 | -63억 | -1,172억 | -55.5% |
| 2023 | 62억 | -62억 | 113억 | -98.6% |
| 2024 | 70억 | -61억 | 161억 | -86.5% |
| 2025 | 63억 | -43억 | -14억 | -68.8% |
| Quarterly | ||||
| 2024 4Q | 22억 | -21억 | 148억 | -97.6% |
| 2025 1Q | 16억 | -13억 | 20억 | -80.6% |
| 2025 2Q | 18억 | -10억 | 11억 | -54.3% |
| 2025 3Q | 21억 | -11억 | 82억 | -49.0% |
| 2025 4Q | 7억 | -10억 | -127억 | -144.3% |
| 2026 1Q | 8억 | -10억 | -147억 | -124.6% |
Company
Address: 서울특별시 강남구 언주로135길 21 2층(논현동)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-31[기재정정]사업보고서 (2025.12)
- 2026-03-23사업보고서 (2025.12)
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-05-14분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.